Seropositivity Rates for Measles, Mumps, and Rubella IgG and Costs Associated with Testing and Revaccination
Open Access
- 23 January 2013
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 20 (3) , 443-445
Abstract
Retrospective analysis of IgG test results and patterns for measles, mumps, and rubella revealed generally high seropositivity rates, with that of mumps being the lowest. A simplified cost analysis shows that when there is a suspicion of nonimmunity, serological testing may be cheaper than vaccination.Keywords
This publication has 9 references indexed in Scilit:
- Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).2011
- Persistence of Rubella Antibodies after 2 Doses of Measles‐Mumps‐Rubella VaccineThe Journal of Infectious Diseases, 2009
- Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella VaccineThe Journal of Infectious Diseases, 2009
- Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programmeThe Lancet Infectious Diseases, 2008
- Long‐Term Persistence of Mumps Antibody after Receipt of 2 Measles‐Mumps‐Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University PopulationThe Journal of Infectious Diseases, 2008
- Recent Resurgence of Mumps in the United StatesNew England Journal of Medicine, 2008
- Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐upThe Journal of Infectious Diseases, 2008
- Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).1998
- Mumps--United States, 1985-1986.1987